Novo Nordisk drops 5% after rival Amgen teases weight-loss drug data
Go back to Novo Nordisk drops 5% after rival Amgen teases weight-loss drug data| Amgen Inc (NASDAQ: AMGN) | Delayed: 393.17 -44.06 (10.08%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $437.23 | 52 Week High | $176.85 | |||
| Open | $408.90 | 52 Week Low | $133.64 | |||
| Day High | $410.03 | P/E | 59.21 | |||
| Day Low | $391.17 | EPS | $6.64 | |||
| Volume | 6,830,896 | |||||
| Lilly (Eli) & Co. (NYSE: LLY) | Delayed: 1123.91 -25.45 (2.21%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $1149.36 | 52 Week High | $88.16 | |||
| Open | $1133.00 | 52 Week Low | $67.88 | |||
| Day High | $1134.53 | P/E | 260.16 | |||
| Day Low | $1113.55 | EPS | $4.32 | |||
| Volume | 2,402,850 | |||||
| NOVO-NORDISK A/S (NYSE: NVO) | Delayed: 45.16 -1.44 (3.09%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $46.60 | 52 Week High | $59.00 | |||
| Open | $45.58 | 52 Week Low | $32.80 | |||
| Day High | $45.91 | P/E | N/A | |||
| Day Low | $45.15 | EPS | $0.00 | |||
| Volume | 10,349,761 | |||||

